These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. The natural history of elevated tetradecenoyl-L-carnitine detected by newborn screening in New Zealand: implications for very long chain acyl-CoA dehydrogenase deficiency screening and treatment. Ryder B; Knoll D; Love DR; Shepherd P; Love JM; Reed PW; de Hora M; Webster D; Glamuzina E; Wilson C J Inherit Metab Dis; 2016 May; 39(3):409-414. PubMed ID: 26743058 [TBL] [Abstract][Full Text] [Related]
28. The first case of mitochondrial acetoacetyl-CoA thiolase deficiency identified by expanded newborn metabolic screening in Italy: the importance of an integrated diagnostic approach. Catanzano F; Ombrone D; Di Stefano C; Rossi A; Nosari N; Scolamiero E; Tandurella I; Frisso G; Parenti G; Ruoppolo M; Andria G; Salvatore F J Inherit Metab Dis; 2010 Dec; 33 Suppl 3(Suppl 3):S91-4. PubMed ID: 20157782 [TBL] [Abstract][Full Text] [Related]
29. [Newborn Screening Program in the Community of Madrid: evaluation of positive cases.]. Cambra Conejero A; Martínez Figueras L; Ortiz Temprado A; Blanco Soto P; Martín Rivada Á; Palomino Pérez L; Cañedo Villarroya E; Pedrón Giner C; Quijada Fraile P; Martín-Hernández E; García Silva MT; Chumillas Calzada S; Bellusci M; Belanger-Quintana A; Stanescu S; Martínez-Pardo Casanova M; Moráis López A; Bergua Martínez A; Ruiz-Salas P; Pérez González B; Ugarte M; Ruano MLF Rev Esp Salud Publica; 2020 Dec; 94():. PubMed ID: 33372917 [TBL] [Abstract][Full Text] [Related]
30. Systematic review and meta-analysis to estimate the birth prevalence of five inherited metabolic diseases. Moorthie S; Cameron L; Sagoo GS; Bonham JR; Burton H J Inherit Metab Dis; 2014 Nov; 37(6):889-98. PubMed ID: 25022222 [TBL] [Abstract][Full Text] [Related]
31. Recurrent ACADVL molecular findings in individuals with a positive newborn screen for very long chain acyl-coA dehydrogenase (VLCAD) deficiency in the United States. Miller MJ; Burrage LC; Gibson JB; Strenk ME; Lose EJ; Bick DP; Elsea SH; Sutton VR; Sun Q; Graham BH; Craigen WJ; Zhang VW; Wong LJ Mol Genet Metab; 2015 Nov; 116(3):139-45. PubMed ID: 26385305 [TBL] [Abstract][Full Text] [Related]
32. Management and diagnosis of mitochondrial fatty acid oxidation disorders: focus on very-long-chain acyl-CoA dehydrogenase deficiency. Yamada K; Taketani T J Hum Genet; 2019 Feb; 64(2):73-85. PubMed ID: 30401918 [TBL] [Abstract][Full Text] [Related]
33. Diagnosis and management of glutaric aciduria type I--revised recommendations. Kölker S; Christensen E; Leonard JV; Greenberg CR; Boneh A; Burlina AB; Burlina AP; Dixon M; Duran M; García Cazorla A; Goodman SI; Koeller DM; Kyllerman M; Mühlhausen C; Müller E; Okun JG; Wilcken B; Hoffmann GF; Burgard P J Inherit Metab Dis; 2011 Jun; 34(3):677-94. PubMed ID: 21431622 [TBL] [Abstract][Full Text] [Related]
34. Fatty acid oxidation flux predicts the clinical severity of VLCAD deficiency. Diekman EF; Ferdinandusse S; van der Pol L; Waterham HR; Ruiter JP; Ijlst L; Wanders RJ; Houten SM; Wijburg FA; Blank AC; Asselbergs FW; Houtkooper RH; Visser G Genet Med; 2015 Dec; 17(12):989-94. PubMed ID: 25834949 [TBL] [Abstract][Full Text] [Related]
35. Evaluation of the first 5 years of a glutaric aciduria type I neonatal screening programme in Asturias. Elola Pastor AI; Prieto García B; Díaz Martín JJ An Pediatr (Engl Ed); 2024 May; 100(5):318-324. PubMed ID: 38714461 [TBL] [Abstract][Full Text] [Related]
36. Very long-chain acyl-CoA dehydrogenase deficiency: the effects of accidental fat loading in a patient detected through newborn screening. Ficicioglu C; Hussa C J Inherit Metab Dis; 2009 Dec; 32 Suppl 1():S187-90. PubMed ID: 19333779 [TBL] [Abstract][Full Text] [Related]
37. [Clinical and laboratory studies on 28 patients with glutaric aciduria type 1]. Wang Q; Ding Y; Liu Y; Li X; Wu T; Song J; Wang Y; Yang Y Zhonghua Er Ke Za Zhi; 2014 Jun; 52(6):415-9. PubMed ID: 25190159 [TBL] [Abstract][Full Text] [Related]
38. The first three years of screening for medium chain acyl-CoA dehydrogenase deficiency (MCADD) by newborn screening ontario. Kennedy S; Potter BK; Wilson K; Fisher L; Geraghty M; Milburn J; Chakraborty P BMC Pediatr; 2010 Nov; 10():82. PubMed ID: 21083904 [TBL] [Abstract][Full Text] [Related]
39. Genetic characteristics and follow-up of patients with fatty acid β-oxidation disorders through expanded newborn screening in a Northern Chinese population. Wang S; Leng J; Diao C; Wang Y; Zheng R J Pediatr Endocrinol Metab; 2020 May; 33(6):683-690. PubMed ID: 32447334 [TBL] [Abstract][Full Text] [Related]